SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+35.56%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$581M
AUM Growth
–
Cap. Flow
+$581M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
91.59%
Holding
53
New
51
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$162M |
| 2 |
NCNA
NuCana
NCNA
|
$88.3M |
| 3 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$64.1M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$41.5M |
| 5 |
Merus
MRUS
|
$36.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 94.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cidara Therapeutics
CDTX
$1.66B
| $52K | 0.01% | +12,952 | New | +$52K |
|
52
Exelixis
EXEL
$10.1B
| – | – | 0 | – | – |
|
|
SPPI
53
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| – | – | 0 | – | – |
|